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Abstract
Vasoregression is a hallmark of vascular eye diseases but the mechanisms involved are still largely unknown. We have
recently characterized a rat ciliopathy model which develops primary photoreceptor degeneration and secondary
vasoregression. To improve the understanding of secondary vasoregression in retinal neurodegeneration, we used
microarray techniques to compare gene expression profiles in this new model before and after retinal vasoregression.
Differential gene expression was validated by quantitative RT-PCR, Western blot and immunofluorescence. Of the 157 genes
regulated more than twofold, the MHC class II invariant chain CD74 yielded the strongest upregulation, and was allocated to
activated microglial cells close to the vessels undergoing vasoregression. Pathway clustering identified genes of the
immune system including inflammatory signaling, and components of the complement cascade upregulated during
vasoregression. Together, our data suggest that microglial cells involved in retinal immune response participate in the
initiation of vasoregression in the retina.
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Introduction
Regression of the matured retinal vasculature in adults is often
initiated by pericyte loss and subsequent degeneration of
endothelial cells [1,2]. Extended vasoregression can result in
hypoxia, and the dense retinal vascular network adapts to the high
metabolic demands of neurons which are in close proximity to
each other. Neurodegeneration such as retinitis pigmentosa leads
to secondary vascular attenuation, leakage and functional
limitations [3,4]. Some investigations also suggest that damage of
retinal glial cells (astrocytes, Mu ¨ller cells and microglia) precedes
vascular impairment [2,5]. Microglial activation has been found in
a variety of retinal pathologies such as photoreceptor degenera-
tion, diabetes and ischemia- reperfusion [6,7,8]. However, the link
between microglial activation and vasoregression is unclear.
The processes involved in the maturing vessels, comprise
recruitment signals for pericytes, organization of basement
membrane components, and secretion of inhibitors of (metallo-)
proteases [9]. Consequently, regression of mature vessels requires
the erroneous abrogation of survival promoting signals, and the
aberrant activation of matrix-degrading proteases, among others.
For example, in the diabetic retina, dropout of pericytes is
conceived as a primary step in the reactivation of the endothelium,
reducing endothelial protection [10]. The progressive indepen-
dence of vessels for survival signals is one important characteristic
of mature vessels. If VEGF is conditionally reduced in retinal tissue
during postnatal development, it results in a loose capillary
network with numerous regressive capillary profiles. However,
when VEGF is inhibited during adulthood, there is no induction of
vasoregression [11].
Impaired capillary formation is observed when neurodegen-
eration starts before the completion and maturation of the
retinal network in animal models [12]. This contrasts with our
observations in a novel model of adult retinal vasoregression.
We recently characterized this transgenic rat displaying
neuronal and vascular degeneration, and discovered that
vasoregression ensues after the retinal capillary system had fully
developed, preceded by neurodegeneration [13]. In this model,
dropout of vascular pericytes, and capillary occlusions became
evident after the second month of life. Thus, a precise image of
the temporal and structural evolution of retinal vascular
degeneration exists.
Despite an extensive vasoregression, hypoxia and instructive
VEGF regulations were absent in this model, while some
neurotrophins were upregulated, suggesting that a. the response
to injury was probably inadequate, and b. other mechanisms are
involved in the extensive vasoregressive process.
Therefore, in order to identify genes and signaling pathways
involved in retinal vasoregression in this rat model, we
performed a microarray analysis before and after the initiation
of vasoregression. We observed a pronounced implication of
components of the immune and the complement system, and
identified CD74 specifically upregulated in perivascular microg-
lia of the deep capillary in which the primary vascular lesion
occurs.
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Animals
All experiments in this study were performed in accordance with the
ARVO statement for the use of animals ophthalmic and vision
research, and the regional animal ethics committee. This study was
approved by the ethics committee Regierungspra ¨sidium Karlsruhe,
approval ID: 35-9185.81/G-93/05. Male homozygous PKD-2-247
rats (TGR) and male Sprague-Dawley (SD) rats were used as controls.
Generation and genotyping of the transgenic rats were described
previously [14]. The rats were held in a 12 hours light and dark cycle
with free access to food and drinking water. At 1 and 3 months of age,
SD and TGR rats were anesthetized, and after sacrifice the eyes were
immediately frozen for later preparation of total RNA, retina
homogenate and whole mount retinal immunofluorescence staining.
RNA isolation
Retinal total RNA was individually extracted using Trizol reagent
(Invitrogen,Germany)according to themanufacturer’sprotocol.The
quality and purity of RNA were controlled spectrophotometrically
and estimated by electrophoresis on a 1% agarose gel.
Microarrays and pathway analysis
cDNA and cRNA synthesis, and hybridization to arrays of type
Rae230_2 from Affymetrix (Santa Clara, CA, USA) were
performed according to the recommendations of the manufacturer.
Three arrays were applied for each combination of rat transgene
(TGR/SD) and age (1-month and 3-month). A total of 12 arrays
were hybridized. The dependency of gene expression on rat
transgene or age was analyzed using JMP Genomics (SAS Institute,
Cary, NC, USA). Signals were first log transformed and quantile
normalized, before being subjected to mixed model ANOVA, by
which rat transgene and age as well as probe were considered as
fixed effects and array-id as random. An ORA approach using
Fisher’s exact test was taken to identify pathways listed in Kyoto
Encyclopedia of Genes and Genomes that are likely to be affected
by differential gene expression. Additionally, gene set enrichment
analysis (GSEA, version 2.0) and Ingenuity Systems software
(Ingenuity Systems, Redwood City, CA, USA) were applied to
reveal biological pathways modulated by rat transgene or age.
Genes were ranked according to their expression levels. All Gene
Ontology terms were examined using 1000 rounds of permutation
of gene sets. MIAME compliant microarray data were submitted to
Gene Expression Omnibus (GEO), sample number GSE20967.
Quantitative real time PCR
For quantitative real time PCR, retinal total RNA was isolated using
Trizol according to the manufacturer’s protocol. The cDNA synthesis
with removal of genomic DNA was performed using the QuantiTectH
Reverse Transcription kit (Qiagen GmbH, Hilden, Germany).
TaqMan 2xPCR master Mix (Applied Biosystems, Weiterstadt,
Germany) was applied for real time PCR. A volume of 20 mlo f
amplification reactions contained 0.4 mlc D N A ,1 xM a s t e rM i x ,
0.9 mM each primers and 0.25 mM probe. The samples were amplified
using an ABI 7000 Real Time PCR System (Applied Biosystems,
Darmstdt, Germany). Thermal cycling was carried out for 2 min at
50uC, then, for 10 min at 95uC, followed by 40 cycles of 15 sec at 95u
and 1 min at 60uC. All primers and MGB probes labelled with FAM
for amplification were purchased from Applied Biosystems: A2M, Rn
01459605_m1; B2M, Rn 00560865_m1; CD74, Rn 00565062_m1;
CEBPB, Rn 00824635_s1; CFB, Rn 01526084_g1; CTSS, Rn
00569036_m1; RT1-DA, Rn 01427980_m1; Serping1, Rn
01485600_m1; C1qa, Rn 01519903_m1; TNFRSF1A, Rn
01492348_m1; IL-1b, Rn 00580432_m1; b-Actin, Rn
00667869_m1. Expression of genes was analysed by the 2
2DDCT
method using b-actin as a reference gene.
Western blot
To assess protein expression of genes of interest, retinal proteins
were individually extracted from TGR and SD rats of 1 and 3
months of age. The retinas were homogenized in 0.1% SDS buffer
containing 125 mM NaCl, 10 mM EDTA, 25 mM Hepes,
10 mM Na3VO4, 0.5% deoxycholic acid, 0.1% SDS, 1% Triton
X-100 with Complete
TM protease inhibitor cocktail (Roche
Diagnostic GmbH, Mannheim, Germany). The lysate was
centrifuged at 10,000 rpm for 10 min. The supernatant was then
collected and the protein concentration was determined with the
Bradford protein assay according the manufacturer’s protocol. 20–
40 mg proteins were separated on 10–20% SDS gels under
reducing conditions. Furthermore, the proteins were then
transferred onto PVDF membranes and the membranes were
blocked with 5% bovine serum albumin or 5% non-fat dry milk in
Tris buffered with Tween-20 for 1 h to reduce non-specific
binding. Then, the Blot was incubated with primary antibody over
night at 4uC. After washing, they were further incubated with
HRP-conjugated secondary antibody for 2 hours at room
temperature. Finally, the signals were detected with enhance
chemiluminescence (ECL) and exposed to X-film.
Retinal Immunofluorescence
For whole mount retinal immunofluorescence staining, eyes were
fixed in 4% paraformaldehyde overnight. After dissection retinas
were washed in PBS and incubated in permeabilization and
blocking buffer containing1%BSAand 0.5%Tritonfor1 hour.For
detecting microglia activation, mouse anti CD11b (1:100, AbD
Serotec, Du ¨sseldorf, Germany) or rabbit anti rat Iba1 (1:50 DAKO,
Hamburg, Germany), rabbit anti CD74 (Santa Cruz, Heidelberg,
Germany) and Lectin labelled with biotin (1:100, Sigma, Munich,
Germany) wereused. The corresponding secondary antibodies used
were goat anti mouse IgG Alexa 488 (1:200, Invitrogen, Karlsruhe,
Germany), swine anti rabbit labelled with Tritc (1:20, DAKO,
Hamburg, Germany) and streptavidin labelled with Alexa 633
(1:200, Invitrogen, Karlsruhe, Germany) for CD11b, CD74 and
Lectin. For determination of CD74 expression in pericytes, rabbit
anti NG2 (1:200, Chemicon, Germany), goat anti CD74 (1:50,
Santa Cruz, Heidelberg, Germany) and Lectin labelled with biotin
(1:100, Sigma, Munich, Germany) were used. The corresponding
secondary antibodies used were swine anti rabbit-TRITC (DAKO,
Hamburg, Germany, 1:20), donkey anti goat FITC (Acris, 1:100)
and streptavidin labelled with Alexa 633 (1:200, Invitrogen,
Karlsruhe, Germany) for CD11b, CD74 and Lectin, respectively.
After washingin PBS, the retinas were flat mounted in 50%glycerol
and photos were taken with a confocal microscope (Leica TCS SP2
Confocal Microscope, Leica, Wetzlar, Germany).
Statistical analysis
Statistical analysis for microarray data was summarized above.
Data of transcriptional expression are presented with mean and
standard error. Analysis of variance (ANOVA) with Bonferroni post-
test was performed to determine the significance between the groups.
A p value less than 0.05 was considered as statistically significant.
Results
Genes and pathways involved in the development of
vasoregression
To identify genes and pathways involved in the development of
vasoregression in TGR retinas, gene expression profiling was
Microglial Cells in Retinal Vasoregression
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and after initiation of vasoregression, respectively. The Affymetrix
GeneChipH for rat expression array 230 2.0 was used. The array
comprised of more than 31,000 probe sets for analysing over
30,000 transcripts and variants from over 28,000 rat genes. 3267
genes were significantly upregulated while 2924 genes were
significantly downregulated when significance level (p-value) of
less than 0.001 was defined as cutoff between TGR and SD rats.
Moreover, hierarchical clustering of rat groups was performed
based on differential gene expression (Figure 1). Genes of SD rats
at 1 and 3 months exhibited similar expression patterns, and had a
high comparability to the gene expression patterns of TGR rats at
1 month of age. 3-month old TGR rats demonstrated major
changes in gene expression (Figure 2).
Next, we focused on genes which were differentially expressed
in 3-month TGR over time (i.e. compared with 1-month TGR)
and compared with controls (i.e. 3-month SD rats). As displayed in
the volcano plot, a number of genes in 3-month TGR retinas
exhibited significant expression changes when compared with 1-
month TGR, and with 3-month SD rats. 374 genes were .2
+1 or
,2
21 significantly regulated during development of vasoregression
(Table S1). Of these genes, 157 genes in 3-month TGR were more
than 2-fold upregulated whereas 216 genes in this group were
more than 50% downregulated in comparison with the two other
groups. CD74 (invariant polypeptide of major histocompatibility
complex, class II antigen-associated), Lgals3 (Lectin-galactose
binding-soluble 3), and Serping1 (serine peptidase inhibitor-clade
G, member 1) were the genes with the strongest upregulation in
the 3-month TGR while Slc31a2 (solute carrier family 31-member
2), Hk2 (Hexokinase 2), Pax4 (paired box gene 4) and Rdh12
(retinol dehydrogenase 12) were ,90% down-regulated. In
contrast, there were only few genes which were regulated between
TGR and SD retinas at 1 month, and in SD retinas between 1 and
3 months (Figure 2).
Additionally, to examine the potential biological relevance of
the transcriptome response during vasoregression, differentially
expressed genes were classified according to their biological
processes defined in Gene Ontology (GO) and Kyoto Encyclope-
dia of Genes and Genomes (KEGG). Functional analysis using
GO revealed that a number of specific pathways were actively
involved in the development of vasoregression in TGR rats at 3
months. Fourty pathways in GO were significantly upregulated
during vasoregression in 3-month TGR compared with 1-month
TGR and 3-month SD retinas. On the other hand, a total of five
pathways were upregulated in KEGG. Furthermore, genes
involved in the immune system including inflammatory and
complementary response, cell signalling via receptors, especially
protein tyrosine kinase activity, exhibited strong correlation with
vasoregression. Some genes were shared by different pathways,
such as CD74 antigen in the immune effector process, in antigen
processing and presentation, in inflammatory response and in
cytokine binding; CCAAT/enhancer binding protein beta
(CEBPB) was shared in pathways of the immune response, in
defence response and in inflammatory response. Figure 3 depicts
the two central pathways, i.e. the antigen presentation pathways,
and the acute response pathway, and their relationships.
Transmembrane receptor tyrosine kinases, which are relevant
for vascular development and remodelling such as tyrosine kinase
with immunoglobulin-like and EGF-like domains 1 (Tie1), VEGF
receptor-2 (KDR), VEGF receptor-1 (FLT1), platelet-derived
growth factor receptor alpha (PDGFRA), Epidermal-Growth-
Factor-Receptor (EGFR) and fibroblast growth factor receptors
(FGFR) were also found to be significantly changed (data not
shown).
As internal validation, and based on previous results, we found
GFAP 9 fold upregulated in the 3-month TGR rats compared
with their age-matched controls in the array analysis [13].
Validation of microarray data by quantitative real-time
PCR
To validate the differential transcriptional gene expression
observed on microarray analysis, we carried out TaqMan probe
based on quantitative real-time PCR with independently retrieved
TGR and SD retinas at 1 and 3 months of age. As shown in
Figure 4, mRNA levels of CD74 were high in TGR retinas at 3
months, whereas expression of CD74 was low in TGR retinas at 1
month and SD retinas at 1 and 3 months. Similarly, A2M (alpha-
2-macroglobulin), B2M (beta-2-macroglobulin), CEBPB, CFB
Figure 1. Hierarchical clustering analysis of gene profiling in
SD and TGR rats at 1- and 3-month. Only genes with negative
log10 P.10 are shown on the clustering diagram. The diagram shows
that TGR 1-month, SD 1- and 3-month have similar gene expression
profiling whereas 3-month TGR differs markedly from these three
groups. Red indicates high and blue low expression of the single gene
compared with the mean. The fold changes in the bar are represented
in log2X. A: 1-month TGR; B: 1-month SD; C: 3-month SD; D: 3-month
TGR.
doi:10.1371/journal.pone.0016865.g001
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II, locus Da), SERPING1 (serine/cysteine peptidase inhibitor,
clade G, member 1), C1qa (complement component 1, q
subcomponent, alpha polypeptide) and TNFRSF1A (Tumor
necrosis factor receptor superfamily member 1A) were expressed
significantly higher in 3-month TGR retinas than in other three
groups. These ten genes retrieved from microarray analysis were
fully confirmed in quantitative real time PCR. Expression of
CD74 detected was 19-fold higher in 3-month TGR retinas
compared with age-matched SD rats in real time PCR analysis.
Upregulated transcripts of B2M (3-fold), RT1-DA (23-fold) and
CTSS (3-fold) which participate in antigen processing and
presentation were confirmed by quantitative real-time PCR.
Furthermore, complement regulation mediated by CFB (16-fold),
SERPING1 (7-fold), and C1qa (3-fold) was also confirmed by real
time PCR. Upregulation in inflammatory responses via A2M (4-
fold), CEBPB (3-fold), TNFRSF1A (3-fold) and IL-1b (2-fold) were
also confirmed. Thus, the expression levels of regulated genes from
microarray analysis were fully confirmed by quantitative real time
PCR.
CD-74 expressing microglia localizes to retinal
vasoregression
To investigate translational expression levels of CD74 obtained
on the microarray, we performed western blot analysis with retinal
lysates from TGR and SD rats at 1 and 3 months. Weak CD74
expression was found in the retinas of 1- and 3-month SD and 1-
month TGR rats. A significant overexpression of CD74 protein
was detected in 3-month TGR retinas compared with other three
groups (Figure 5A and B).
Next, we identified by immunofluorescence that CD74 was
expressed in cells close to both, the superficial and deep capillary
layers in SD rats. In contrast, CD74 positive cells were located
predominantly around the deep capillary in TGR rats of one
month of age. The strongest and most obvious accumulation of
CD74-positive cells was found in TGR rats of three months in the
vicinity of the deep capillary layers. CD74 positive cells were either
localized on or closed to the vessels or in the inter-vascular spaces
with prolonged end feet spanning vessels. The morphology of
these cells identified them as microglial cells which were further
confirmed by co-immunostaining with microglial marker CD11b
and Iba-1 (Figure 6A, B, C, D and Figure S1). CD74 was
expressed predominantly in the membrane of cell soma and dot-
like in the processes of microglial cells, whereas CD11b labelled
strongly all processes of microglial cells. Even though CD74-
positive microglial cells were localised close to vessels and some
even seemed morphologiocally like pericytes, immunofluorescence
staining revealed no colocalisation between CD74 positive
microglia cells and pericytes labelled with pericyte-specific marker
NG2 (Figure 6E, F, G, H). 66% CD74 positive microglial cells
were close to the capillaries. Close correlation between CD74
positive microglial cells and regressive vessels was noted in 3-
month TGR retinas (Figure 6I, J, K, L).
We analysed expression of macrophage-inhibiting factor (MIF)
known as ligand for CD74 in various tissues and diseases. We
compared protein expression in the four groups analyzed and did
not find any upregulated expression in the TGR groups (data not
Figure 2. Volcano blots of significance against the fold change of expression of SD and TGR retinas at 1- and 3-month. The diagram
shows that there are numerous genes in 3-month TGR up and down regulated compared with 3-month SD (A) and 1-month TGR (B). Few genes were
differentially expressed among 1-month TGR and SD rats, 1- and 3-month SD rats. Horizontal reference line indicates negative log10 P.10 on the
clustering diagram.
doi:10.1371/journal.pone.0016865.g002
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the neurodegenerative retina.
Discussion
In our model of ciliopathy-associated neurodegeneration, we
identified CD74 and other components of the immunity system,
expressed in microglia, as mediators of secondary vasoregression.
Genes involved in the immune response including inflammatory/
complementary pathways and in tyrosine kinase pathway were
strongly regulated. Our findings suggest that CD74 positive
microglial cells may have a function during the development of
vasoregression in the retina.
The first novel finding in our study suggests that immune system
including antigen processing and presentation, inflammatory and
complementary response plays a predominant role during
vasoregression in TGR rat. Activation of these pathways was
verified by upregulation of CD74/B2M/RT1-DA/CTSS, A2M/
CEBPB/TNFRSF1A/IL-1b and CFB/SERPING1/C1qa, re-
spectively. The representative molecule from antigen processing
and presentation as well as inflammatory pathways during
vasoregression is CD74. CD74 is the invariant chain directing
the trafficking of MHC class II molecules in antigen presenting
cells (APCs) [15]. Previous studies have shown that CD74 is
associated with cancer and inflammatory disease, such as
Helicobacter pylori infection, bladder inflammation, atherosclero-
sis and renal injury [16,17]. Moreover, upregulation of members
of the innate immunity and of the complement cascade has been
uniformly observed in several other animal models of post-
developmental retinal injury (Table S2). For example, the model of
acute IOP elevation resembles the PKD model in that some
components of the innate immunity and the complement system
Figure 3. Antigen presentation and complement component response signaling predicted by Ingenuity Pathway Analysis in the
TGR. All genes whose mRNA expression levels were differentially regulated in the TGR at 3 months are highlighted in red. Genes validated by real-
time PCR are marked by green dotted circles. Symbols depict different gene functions. The upward facing fork shape represents transmembrane
receptor, the right facing forceps shape represents peptidase, the dumbell shape represents transcription regulator.
doi:10.1371/journal.pone.0016865.g003
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microglia was not established. Of note, by comparing our data
with data of other models, the link between CD74 expression on
microglia and the close proximity to vasoregression was not made.
Signal transduction studies indicated that CD74 binds MIF, and
in cooperation with CD44, mediates a variety of ERK1/2 and src
tyrosine kinase-based cellular functions such as endothelial
proliferation, regulation of apoptosis, regulation of arachidonic
and prostaglandin metabolism [18].
Apart from APCs, cancer cells and podocytes, expression of
CD74 is increased in smooth muscle cells undergoing inflamma-
tion and in microglia in neurodegenerative disorder such as
Alzheimer disease [19,20]. We found that CD74 is expressed in
microglial cells during vasoregression in TGR retinas. Of note, our
model represents a ciliopathy-based photoreceptor degeneration
with secondary vascular defects. Thus, our data which show
similarities to gene expression profiles of other inflammatory and
neurodegenerative diseases suggest that CD74 may represent an
important link between inflammatory stimuli and vasoregression.
Interestingly, we observed a strong upregulation of CD74
preceding and accompanying neurodegeneration and vasoregres-
sion in the absence of major changes in retinal MIF levels. Thus,
CD74 mediated tissue damage may indicate a predominant
immune cell mediated antigen processing and presentation
process. This is supported by the finding that various genes of
the complement system such as C1qa, CFB and Serping1 are
highly upregulated in the TGR model.
Antigen binding of C1qa binding is the first step in activating
the classical complement pathway, whereas CFB and Serping1 are
regulators in the alternative and classical complement activation
pathways [21].
Recent genetic studies show that polymorphisms in complement
factor B and H (CFH) are important for the development of age-
related macular degeneration (AMD) and its vascular pathology. A
study from von Leithner et al. demonstrated that CFH is essential in
the maintenance of endothelial function for normal retina perfusion
[22]. Deficiency in CFB causes an autoimmune response directly in
the endothelium of intra-retinal vascular network. Retinal vessels in
CFHknockout mice areprogressively overloadedwith C3andC3b,
leading to vasoconstriction and occlusion. While CFB promotes
complement activation after binding to C3b, CFH suppresses the
activation upon binding to C3b. CFH and CFB are closely
associated with C3 and the formation of C5 convertase. Together,
complement activation can cause vascular damage in a variety of
pathological settings. The multiple interplay of components of the
classical and alternative complement pathway in association with
the activated immune system provide a possible mechanistic link
between photoreceptor-degeneration induced upregulation of
CD74 activation in microglia and secondary vasoregression, but
the causal relationship between complement activation and
vasoregression needs further substantiation.
The proximity of CD74 positive microglia to the capillary
network which is primarily affected in the TGR suggests that these
cells are somehow involved in the onset of vasoregression. Mature
vessels are largely independent of growth survival signals than
immature vessels. Thus, adult vasoregression in the presence of
upregulated survival factors is extraordinary. However, the role of
microglia in the destruction of retinal vessels is suggestive given the
evidence, e.g. from the RCS rat and other models in which
photoreceptor degeneration, microglia activation, and vessel
regression have been demonstrated [6,23,24].
However, neither model has provided evidence that CD74 and
the complement system are central mediators. From our data, we
postulate that defects in cilia of the photoreceptor cells lead to
apoptosis, hypothetically releasing peptides and cell debris that
activate microglial cells.
Our model represents specific features which are considered a
general responsive phenotype of the retina. In a recent review by
Figure 4. Confirmation of gene expression profiles in SD and TGR retinas at 1- and 3-month. Transcriptional analysis of genes was
performed by quantitative real-time PCR in rats of 1-month SD (white bars), 1-month TGR (gray bars), 3-month SD (striped bars) and 3-month TGR
(black bars). The values at 1-month are standardized to 1. *p,0.05, **p,0.01, ***p,0.001: 3-month TGR compared with 1-month TGR. #p,0.05,
###p,0.001: 3-month TGR compared with 3-month SD.
doi:10.1371/journal.pone.0016865.g004
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characteristic multicellular response pattern, including low level
apoptosis, complement activation and inflammatory cytokine
reaction, and the activation of microglia as an important effector
cell. By comparison, the TGR model shares some of these
important characteristics, however, also with some singularities,
such as the extensive vasoregression [25].
Adult vasoregression may be promoted when pericytes are lost
yielding reduced endothelial protection. The TGR has reduced
pericyte coverage over time for unknown reasons, rendering it more
susceptible to vasoregression in analogy to mice with heterozygous
PDGF-B deficiency. Activated microglia is known to secrete
inflammatory cytokines such TNF-alpha and IL-1b which can
activate and subsequently damage endothelial cells [26]. Further
studies inhibiting inflammatory signalling in this model are required
to delineate the importance of these secondary tissue responses.
Of note, some of the genes upregulated in the TGR are
consistent with genes expressed in Mu ¨ller glia isolated from 6
months diabetic SD retinas [27]. These include CD74, RT1-Ba,
C1s, A2M, Timp1 and CEBP. Many genes associated with
immune/inflammatory and acute-phase response produced by
Mu ¨ller cells are also strongly regulated in our TGR rat model.
Interestingly, CD74 was not found in astrocytes or Mu ¨ller cells in
the TGR. Whether this is due to differences in species or in
Figure 5. Expression of CD74 in SD and TGR retinas at 1- and 3 months. A. Translational analysis of CD74 by Western blot. B. quantitative
analysis of translational CD74 expression. The values at 1-month are standardized to 1. C: expression and localization of CD74 in the retina. Vessels are
visualized by staining with Lectin (red), and CD74 positive cells are displayed in green. Few CD74 positive cells are seen in SD in the superficial and
deep capillary layers. A slight increase in number of CD74 positive cells is found in TGR in the superficial capillary layer at 1 month. The numbers of
CD74 positive cells are raised in the deep capillary layer in 3-month TGR compared with other three groups at all time points observed. C–F: the
superficial capillary layer; G–J: the deep capillary layer. 1 m: 1-month retina. 3 m: 3-month retina. *p,0.05: 3-month TGR compared with other three
groups.
doi:10.1371/journal.pone.0016865.g005
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data indicate that vasoregression in TGR retinas shares similarities
with molecular changes induced by chronic hyperglycemia.
As we determined gene expression before and after vessel
regression, the involvement of specific tyrosine kinases in relation to
vasoregression is not surprising. Given the progressive glial response
to the neurodegeneration with concomitant activation and
expression of neurotrophin which share survival activities of vessels,
the responsive upregulation of the respective tyrosine kinase
pathways appears as an epiphenomenon of the ongoing damage.
In summary, our study on analysis of gene expression profiling
identified pathways involved in immune/inflammatory/complement
system that act as regulators in the development of vasoregression in
the degenerating retina. CD74 and activated microglial cells might be
a novel target for interfering with retinal vasoregression.
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Figure S1 Colocalization of Iba 1 and CD74 in the TGR
retina. A: Iba 1; B: CD74; C: Lectin; D: merged image of A–C.
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Table S1 Genes regulated in 3-month TGR retinas compared
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Figure 6. Activation of microglial cells in TGR retinas. Vessels and microglial cells are visualized by staining with Lectin (blue) and CD11b
(green), respectively. CD74 (red) is expressed in microglial cells (A–D). Furthermore, CD74 (green) is not detected in pericytes as demonstrated by the
staining with NG2 (red), a pericyte marker (E–H). Moreover, microglial cells expressing CD74 were found to be close to regressive capillary (I–L).
Arrows in A–D: colocalization of CD74 and CD11b; arrows in E–H: pericyte; arrowheads in E–H: CD74 positive microglial cell. Arrows in I–L: regressive
vessel.
doi:10.1371/journal.pone.0016865.g006
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